Introduction:
By the late-October 2020, more than 42 million confirmed cases of novelCoronavirus disease (Covid-19) and 1.1 million deaths occurred worldwide (1). Several studies reported the correlation between Covid-19 and inflammatory syndromes, such as Guillain-Barre, myocarditis, and encephalitis (2-4). Indeed, a significant proportion of mortality and morbidity in Covid-19 is due to non-pulmonary immune-mediated complications. These syndromes may affect any organ and have a significant role in tissue damage and death (5). We reported a patient with Covid-19 pneumonia, who developed Henoch–Schoenlein purpura (HSP) on his admission.